Company: INDP
Filing Date: 2025-03-13
Form Type: 8-K
Source: 0001493152-25-010138
Chunk: 1

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                          
         99.1      Press Release of Indaptus Therapeutics, Inc., dated March 13, 2025.  
 ────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as Inline                

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  INDAPTUS THERAPEUTICS, INC.                               
  Date:                                                     
  By:                              /s/ Nir Sassi            
  Name:                            Nir Sassi                
  Title:                           Chief Financial Officer